Company: ABBV
Filing Date: 2025-02-20
Form Type: 424B5
Source: 0001104659-25-015715
Chunk: 16

Company: AbbVie Inc.
Filing Date: 2025-02-20
Form: 424B5
Chunk 16
---
% senior notes due 2025 of Allergan Funding SCS (formerly known as Actavis Funding SCS), which have a stated maturity date of March 15, 2025, in an aggregate principal amount of $130.225 million, and, in each case, and to pay any premium and accrued and unpaid interest in respect thereof, and/or (b) for general corporate purposes.

<div align='center'>S-9</div>

TABLE OF CONTENTS

CAPITALIZATION The following table sets forth our capitalization as of December 31, 2024, on an actual basis and as adjusted to give effect to the issuance and sale of the Notes and the application of the estimated net proceeds therefrom (together with cash on hand), including the repurchase, redemption or repayment of the 3.600% senior notes due 2025 and/or the 3.800% senior notes due 2025 and/or the 3.800% senior notes due 2025 of Allergan Funding SCS (formerly known as Actavis Funding SCS), as described in this prospectus supplement. Actual amounts set forth in the table are subject to adjustments and may differ at the time of the consummation of the proposed transactions depending on several factors, including changes in the actual amount of fees and expenses related to the proposed transactions and the outstanding amount of indebtedness at that time. You should read this table in conjunction with the “ Use of Proceeds ” section and the consolidated financial statements and accompanying notes thereto and other financial information, which are incorporated by reference into this prospectus supplement.

| ​                                                        | ​ | ​ | As of December 31, 2024 |   |       |   |   |   |             |   |       |   | ​ |
|:---------------------------------------------------------|:--|:--|:------------------------|:--|------:|:--|:--|:--|:------------|:--|------:|:--|:--|
| (dollars in millions)                                    | ​ | ​ | Actual                  |   |       |   | ​ | ​ | As Adjusted |   |       |   | ​ |
| Cash and equivalents                                     | ​ | ​ | ​                       | $ | 5,524 | ​ | ​ | ​ | ​           | $ | 2,723 | ​ | ​ |
| Total debt and lease obligations:                        | ​ | ​ | ​                       | ​ |     ​ | ​ | ​